Recombinant Human IL-13

Leinco Technologies
Product Code: LEI-I-195
Product Group: Recombinant Proteins
CodeSizePrice
LEI-I-195-25ug25 ug£1,456.00
Quantity:
LEI-I-195-100ug100 ug£2,116.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Interleukin 13 (IL-13), also known as ALRH, is a single-chain, glycosylated polypeptide and a cytokine that is critical in regulating inflammatory and immune responses.1 It is produced primarily by activated Th2 cells, as well as mast cells and Natural Killer (NK) cells.1 The functions of IL-13 overlap considerably with those of IL-4 but these effects are probably less important given the more potent role of IL-4.2 IL-13 exerts its effects through a multi-subunit receptor comprising the alpha chain of the IL-4 receptor (IL-4Rα), and at least one of two known IL-13-specific binding chains (IL13 Rα1 and IL13 Rα2). Most of the biological effects of IL-13, like those of IL-4, are linked to signal transducer and activator of transcription 6 (STAT6).2 Although IL-13 is associated primarily with the induction of airway disease, it also has anti-inflammatory properties. It exerts these anti-inflammatory effects on monocytes and macrophages, and inhibits the expression of inflammatory cytokines such as IL-1beta, TNF-alpha, IL-6 and IL-8. IL-13 has also been shown to enhance B cell proliferation and to induce isotype switching resulting in increased production of IgE.3 Blocking of IL-13 activity inhibits the pathophysiology of asthma.4 Targeted deletion of IL-13 in mice results in impaired Th2 cell development and indicates an important role for IL-13 in the expulsion of gastrointestinal parasites.5 In addition, studies have identified IL-13 expression as a common feature of cHL (classical Hodgkin lymphoma).6 Human and murine IL-13 are cross-species reactive.
NCBI Gene:
3596
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
IL-13

References

1. Wynn, TA. et al. (2003) Annu Rev Immunol. 21: 425 2. Citrin, DE. et al. (2016) Sci Rep. 6:39714.

Related Products

Product NameProduct CodeSupplier 
Anti-Human IL-13LEI-I-156Leinco Technologies Summary Details
Recombinant Rat IL-13LEI-I-220Leinco Technologies Summary Details
Anti-Human IL-13 - BiotinLEI-I-269Leinco Technologies Summary Details
Recombinant Mouse IL-13LEI-I-278Leinco Technologies Summary Details
Anti-Mouse IL-13LEI-I-348Leinco Technologies Summary Details
Anti-Mouse IL-13 - BiotinLEI-I-349Leinco Technologies Summary Details
Anti-Human IL-13 (Clone 32116)LEI-I-634Leinco Technologies Summary Details
Anti-Mouse IL-13 (Clone 38213)LEI-I-665Leinco Technologies Summary Details
Anti-Rat IL-13LEI-I-854Leinco Technologies Summary Details
Anti-Rat IL-13 - BiotinLEI-I-864Leinco Technologies Summary Details
Anti-Rat IL-13 (Clone 296202)LEI-I-874Leinco Technologies Summary Details